Kevin Dalton is Commercialisation Case Manager at UCC Innovation, leading life sciences IP commercialisation and spin-out formation. With 30+ years in the sector and 17 years in tech transfer, he has supported over 15 spinouts that have collectively raised €50M+. Kevin holds an MSc in Biochemistry and advanced qualifications in Corporate Governance and Venture Financing. He is a Registered Technology Transfer Professional (RTTP) and Certified Licensing Professional (CLP).
Innovation Training for ARC Hub for Therapeutics Translational Researchers
To complement excellence in scientific research, successful commercialisation requires research teams to have a strong understanding of their target markets, the specific problems their technologies address, the competitive landscape, and the ability to...
